In March 2025, the company introduced new plans for the immediate-to-purchaser offering of its Wegovy weight loss drug. The company recognized a brand new pharmacy, identified as NovoCare, which might demand shoppers $499 a month for use of the drug, below half the expense of the drug through other pharmaceutical distribution networks.[53]A weight